Immensely High Creatine Kinase Levels in a Case of Rhabdomyolysis Due to Legionnaires' Disease in a Patient on Tofacitinib: A Case Report and Literature Review.

Acute renal failure Legionella Legionnaires' disease Pneumonia Rhabdomyolysis Tofacitinib

Journal

Journal of community hospital internal medicine perspectives
ISSN: 2000-9666
Titre abrégé: J Community Hosp Intern Med Perspect
Pays: United States
ID NLM: 101601396

Informations de publication

Date de publication:
2022
Historique:
received: 06 04 2021
revised: 28 12 2021
accepted: 07 01 2022
entrez: 17 6 2022
pubmed: 18 6 2022
medline: 18 6 2022
Statut: epublish

Résumé

A 58-year-old female patient presented with altered mental status, diarrhea, and fever. She was hospitalized for acute kidney injury [AKI] and a patchy right lower lobe infiltrates on chest X-ray. Subsequent testing revealed rhabdomyolysis and a positive urinary Legionella antigen test. Creatinine kinase [CK] level peaked at 512,820 U/L and was managed with aggressive intravenous hydration and appropriate antibiotic treatment. With clinical signs of resolution of pneumonia, the CK level declined rapidly, however renal function returned to baseline only after 2 months requiring hemodialysis in the meantime. The patient was also on tofacitinib which can rarely contribute to rhabdomyolysis. Legionella infection can cause severe rhabdomyolysis and AKI. Timely diagnosis of Legionella-associated rhabdomyolysis, and prompt treatment with aggressive IV hydration and appropriate antibiotics is required to prevent morbidity and mortality.

Identifiants

pubmed: 35712689
doi: 10.55729/2000-9666.1038
pii: jchimp-12-02-045
pmc: PMC9195066
doi:

Types de publication

Case Reports

Langues

eng

Pagination

45-49

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 Greater Baltimore Medical Center.

Déclaration de conflit d'intérêts

Conflict of interest No conflict of interest.

Références

ASAIO J. 2015 May-Jun;61(3):e14-6
pubmed: 25635933
Clin Infect Dis. 1996 Apr;22(4):642-9
pubmed: 8729203
Case Rep Crit Care. 2019 Jan 29;2019:3472627
pubmed: 30838138
Lancet. 2016 Jan 23;387(10016):376-385
pubmed: 26231463
Intern Med. 2000 Feb;39(2):150-3
pubmed: 10732834
Dig Dis Sci. 2021 Aug;66(8):2732-2743
pubmed: 32816215
J Clin Pathol. 2008 Sep;61(9):1062-3
pubmed: 18552170
J Clin Microbiol. 2016 Feb;54(2):401-11
pubmed: 26659202
Public Health. 2006 Jun;120(6):566-71
pubmed: 16707144
Cureus. 2019 Sep 26;11(9):e5773
pubmed: 31723532
Chest. 2014 Feb;145(2):202-205
pubmed: 24493498
Ther Apher Dial. 2008 Apr;12(2):171-5
pubmed: 18387168
Case Rep Infect Dis. 2015;2015:793786
pubmed: 26682076
Respir Med Case Rep. 2019 Oct 28;28:100962
pubmed: 31720209
J Infect Dis. 2001 Nov 15;184(10):1289-92
pubmed: 11679917
Clin Infect Dis. 1992 Jan;14(1):204-7
pubmed: 1571431
BMJ Case Rep. 2019 Jun 20;12(6):
pubmed: 31227570

Auteurs

Harish Gopalakrishna (H)

Department of Medicine, Saint Agnes Healthcare, Baltimore, MD, USA.

Ahmad Al-Abdouh (A)

Department of Medicine, Saint Agnes Healthcare, Baltimore, MD, USA.

Gayatri B Nair (GB)

Department of Medicine, Saint Agnes Healthcare, Baltimore, MD, USA.

Vinod Solipuram (V)

Department of Medicine, Saint Agnes Healthcare, Baltimore, MD, USA.

Ammer Bekele (A)

Department of Medicine, Saint Agnes Healthcare, Baltimore, MD, USA.

Classifications MeSH